Andrew P. Dhanasopon, MD, Michelle C. Salazar, MD, Jessica R

Slides:

Advertisements

Similar presentations

Usman Ahmad, MD, Zuoheng Wang, PhD, Ayesha S

Advertisements

Elizabeth A. David, MD, David T

Lymphovascular Invasion as a Prognostic Indicator in Stage I Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis Nathan M. Mollberg, DO,

Daniel C. Thomas, MD, MPH, Brian N. Arnold, MD, Jessica R

Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.

Complete Thoracic Mediastinal Lymphadenectomy Leads to a Higher Rate of Pathologically Proven N2 Disease in Patients With Non-Small Cell Lung Cancer

Sarah J. Gao, BS, Christopher D. Corso, MD, PhD, Elyn H

Roland Assi, MD, MMS, Daniel J. Wong, MD, Daniel J. Boffa, MD, Frank C

Prediction of Long-Term Survival After Lung Cancer Surgery for Elderly Patients in The Society of Thoracic Surgeons General Thoracic Surgery Database

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

Now or Later: Evaluating the Importance of Chemotherapy Timing in Resectable Stage III (N2) Lung Cancer in the National Cancer Database Daniel J. Boffa,

Video-Assisted Thoracoscopic Lobectomy for Lung Cancer: Current Practice Patterns and Predictors of Adoption Justin D. Blasberg, MD, Christopher W. Seder,

Comparison of Thoracoscopic Segmentectomy and Thoracoscopic Lobectomy for Small-Sized Stage IA Lung Cancer Chenxi Zhong, MD, Wentao Fang, MD, Teng Mao,

Adjuvant Chemotherapy for T3 Non–Small Cell Lung Cancer with Additional Tumor Nodules in the Same Lobe Michelle C. Salazar, MD, Joshua E. Rosen, BASc,

Joshua E. Rosen, BASc, Hari B

Sarcomatoid Carcinoma of the Lung: A Predictor of Poor Prognosis

Zhiqiang Xue, MD, Fengying Wu, MD, Karlyn E

Elliot Wakeam, MD, MPH, Meredith Giuliani, MBBS, MEd, Natasha B

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small.

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

Outcomes of unexpected pathologic N1 and N2 disease after video-assisted thoracic surgery lobectomy for clinical stage I non–small cell lung cancer Hong.

Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases

Lobectomy in Octogenarians With Non-Small Cell Lung Cancer: Ramifications of Increasing Life Expectancy and the Benefits of Minimally Invasive Surgery

Lymph Node Evaluation by Open or Video-Assisted Approaches in 11,500 Anatomic Lung Cancer Resections Daniel J. Boffa, MD, Andrzej S. Kosinski, PhD, Subroto.

Brian N. Arnold, MD, Daniel C. Thomas, MD, MPH, Joshua E

Induction Chemotherapy is Not Superior to a Surgery-First Strategy for Clinical N1 Non- Small Cell Lung Cancer Paul J. Speicher, MD, Zachary W. Fitch,

David T. Cooke, MD, Danh V. Nguyen, PhD, Ying Yang, MS, Steven L

Joshua E. Rosen, BASc, Michelle C

Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer Robert E. Merritt, MD, Chuong D. Hoang, MD,

Prognostic Predictors in Non-Small Cell Lung Cancer Patients Undergoing Intentional Segmentectomy Terumoto Koike, MD, PhD, Teruaki Koike, MD, PhD, Yasushi.

Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H

Linda Henry, PhD, RN, Linda Halpin, MSN, RN, Sharon Hunt, MBA, Sari D

Philip W. Smith, MD, Hongkun Wang, PhD, Leo M. Gazoni, MD, K

Readmission to Intensive Care Unit After Initial Recovery From Major Thoracic Oncology Surgery Suk-Won Song, MD, Hyun-Sung Lee, MD, PhD, Jae-Hyun Kim,

Community-Based Multidisciplinary Computed Tomography Screening Program Improves Lung Cancer Survival Daniel L. Miller, MD, William R. Mayfield, MD,

Joshua E. Rosen, BASc, Jacquelyn G. Hancock, BS, Anthony W

Asad A. Shah, MD, Mathias Worni, MD, MHS, Christopher R

Improved Lymph Node Staging in Early-Stage Lung Cancer in the National Cancer Database Seth B. Krantz, MD, Waseem Lutfi, BS, Kristine Kuchta, MS, Chi-Hsiung.

Percutaneous Intervention Before Coronary Artery Bypass Surgery Does Not Unfavorably Impact Survival: A Single-Center Propensity-Matched Analysis Suvitesh.

Impact of Lepidic Component Occupancy on Effects of Adjuvant Chemotherapy for Lung Adenocarcinoma Shinsuke Sasada, MD, PhD, Yoshihiro Miyata, MD, PhD,

Quality Measures in Clinical Stage I Non-Small Cell Lung Cancer: Improved Performance Is Associated With Improved Survival Pamela Samson, MD, MPHS, Traves.

Characteristics Associated With the Use of Nonanatomic Resections Among Medicare Patients Undergoing Resections of Early-Stage Lung Cancer Anthony W.

Survival After Lobectomy Versus Segmentectomy for Stage I Non-Small Cell Lung Cancer: A Population-Based Analysis Bryan A. Whitson, MD, PhD, Shawn S.

Age-Dependent Gender Disparities in Post Lung Transplant Survival Among Patients With Idiopathic Pulmonary Fibrosis Shahid I. Sheikh, MD, Don Hayes,

Use of Amiodarone After Major Lung Resection

Abel Gómez-Caro, MD, Pedro Arguis, MD The Annals of Thoracic Surgery

Prognostic Significance of Surgical-Pathologic N1 Lymph Node Involvement in Non- Small Cell Lung Cancer Adalet Demir, MD, Akif Turna, MD, PhD, FETCS,

Number of Lymph Nodes Associated With Maximal Reduction of Long-Term Mortality Risk in Pathologic Node-Negative Non–Small Cell Lung Cancer Raymond U.

Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer Lisa M. Brown, MD, Brian.

Daniel C. Thomas, MD, MPH, Justin D. Blasberg, MD, Brian N

Differences in Patterns of Recurrence in Early-Stage Versus Locally Advanced Non- Small Cell Lung Cancer Feiran Lou, MD, MS, Camelia S. Sima, MD, MS,

Lung Function and ECMO After Lung Transplantation

Sublobar Resection Provides an Equivalent Survival After Lobectomy in Elderly Patients With Early Lung Cancer Jiro Okami, MD, PhD, Yuri Ito, PhD, Masahiko.

Lymph Node Assessment and Impact on Survival in Video-Assisted Thoracoscopic Lobectomy or Segmentectomy Haiyu Zhou, MD, Luis F. Tapias, MD, Henning A.

Jonathan D. Spicer, MD, PhD, Jitesh B. Shewale, BDS, PhD, David B

Arman Kilic, BS, Matthew J. Schuchert, MD, Brian L

Bolstering the Case for Lobectomy in Stages I, II, and IIIA Small-Cell Lung Cancer Using the National Cancer Data Base Susan E. Combs, MA, Jacquelyn.

Shared Decision Making and Effective Risk Communication in the High-Risk Patient With Operable Stage I Non-Small Cell Lung Cancer Pamela Samson, MD,

Defining Patient-Prosthesis Mismatch and Its Effect on Survival in Patients With Impaired Ejection Fraction David A. Cotoni, DO, Robert T. Palac, MD,

Pneumonectomy After Chemoradiation Therapy for Non-Small Cell Lung Cancer: Does “Side” Really Matter? Anthony W. Kim, MD, L. Penfield Faber, MD, William.

Clinical Outcome After Pulmonary Resection for Lung Cancer Patients on Hemodialysis Toshiro Obuchi, MD, Wakako Hamanaka, MD, Yasuhiro Yoshida, MD, Jun.

Survival and Outcomes of Pulmonary Resection for Non-Small Cell Lung Cancer in the Elderly: A Nested Case-Control Study Robert J. Cerfolio, MD, Ayesha.

Surveillance Epidemiology and End Results Evaluation of the Role of Surgery for Stage I Small Cell Lung Cancer James B. Yu, MD, Roy H. Decker, MD, PhD,

Mark I. Block, MD The Annals of Thoracic Surgery

Lobectomy Versus Limited Resection in T1N0 Lung Cancer

John R. Handy, MD, HonD, Kelly Denniston, RHIT, Gary L

Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD

Early Surgical Results After Pneumonectomy for Non-Small Cell Lung Cancer are not Affected by Preoperative Radiotherapy and Chemotherapy Tomas Gudbjartsson,

Treating Locally Advanced Disease: An Analysis of Very Large, Hilar Lymph Node Positive Non-Small Cell Lung Cancer Using the National Cancer Data Base

Presentation transcript:

Fate of Pneumonectomy Patients Variably Captured by Non-Small Cell Lung Cancer Staging System Andrew P. Dhanasopon, MD, Michelle C. Salazar, MD, Jessica R. Hoag, PhD, Joshua E. Rosen, BASc, Anthony W. Kim, MD, Frank C. Detterbeck, MD, Justin D. Blasberg, MD, Daniel J. Boffa, MD The Annals of Thoracic Surgery Volume 104, Issue 6, Pages 1829-1836 (December 2017) DOI: 10.1016/j.athoracsur.2017.06.073 Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Five-year adjusted overall survival of patients who underwent lobectomy, left pneumonectomy, or right pneumonectomy for non-small cell lung cancer. (A) Pathologic stage I, (B) pathologic stage II, and (C) pathologic stage III. (CI = confidence interval; HR = hazard ratio; ref = reference.) The Annals of Thoracic Surgery 2017 104, 1829-1836DOI: (10.1016/j.athoracsur.2017.06.073) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

Supplemental Figure 1 The Annals of Thoracic Surgery 2017 104, 1829-1836DOI: (10.1016/j.athoracsur.2017.06.073) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

Supplemental Figure 2 The Annals of Thoracic Surgery 2017 104, 1829-1836DOI: (10.1016/j.athoracsur.2017.06.073) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions